Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-257977
Filing Date
2024-11-14
Accepted
2024-11-14 07:00:28
Documents
2
Group Members
FORBION CAPITAL FUND II COOPERATIEF U.A.FORBION II MANAGEMENT B.V.FORBION IV MANAGEMENT B.V.FORDYNE B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d912866dsc13ga.htm SC 13G/A 102989
2 EX-99.1 d912866dex991.htm EX-99.1 9029
  Complete submission text file 0001193125-24-257977.txt   113702
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91706 | Film No.: 241457059
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 356993000
Forbion Capital Fund IV Cooperatief U.A. (Filed by) CIK: 0001823747 (see all company filings)

EIN.: 981445896 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A